Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Sabic Agri-Nutrients Company is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to a single distinct art unit, which implies that the subject matter is technically related within the biotech sector. The concentration in one art unit can often lead to a more predictable prosecution environment due to the shared technical expertise of the unit.
The portfolio involves 2 distinct examiners. WERTZ, ASHLEE ELIZABETH is the busiest examiner, with 1 pending office action. Because there are 2 distinct examiners for the pending office actions, the company's success is not tied to a single individual's review. This distribution requires the practitioner to adapt to the specific styles of two different examiners. While WERTZ, ASHLEE ELIZABETH handles one matter, the other pending action is subject to a separate evaluation, providing a diversified prosecution risk across the 2 pending office actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LANGEL, WAYNE A | 1 | 78.4% | +23.2% |
| WERTZ, ASHLEE ELIZABETH | 1 | 52.9% | +42.1% |
| CELSA, BENNETT M | 1 | 33.3% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18702830 | Continuous Methods for Forming Methylene Urea-Isobutylene Diurea Granules | CELSA, BENNETT M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18711303 | Fertilizer Composition Including Multi-Micronutrients | WERTZ, ASHLEE ELIZABETH | 8d |
| 18711373 | Methods of Making Urea Calcium Sulfate (UCS) Using High Shear Mixing | LANGEL, WAYNE A | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18711373 | Methods of Making Urea Calcium Sulfate (UCS) Using High Shear Mixing | LANGEL, WAYNE A | — | §103 | Non-Final OA | — | Pending | May 17, 2024 |
| 18711303 | Fertilizer Composition Including Multi-Micronutrients | WERTZ, ASHLEE ELIZABETH | 1612 | §103DP | Final Rejection | 8d | Pending | May 17, 2024 |
| 18702830 | Continuous Methods for Forming Methylene Urea-Isobutylene Diurea Granules | CELSA, BENNETT M | — | §102§103 | Non-Final OA | — | Pending | Apr 19, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial